Plasma connective tissue growth factor (CTGF/CCN2) levels predict myocardial infarction in the veterans affairs diabetes trial (VADT) cohort
Diabetes Care Feb 03, 2018
Hunt KJ, et al. - The experts embraced this study to determine the role of connective tissue growth factor also known as CCN2 (CTGF/CCN2) as a predictor of cardiovascular events in type 2 diabetes in the Veterans Affairs Diabetes Trial (VADT) cohort. Among patients with type 2 diabetes, high levels of CTGF/CCN2 was noted to predict future myocardial infarction and cardiovascular death.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
